Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingInterventional

Piloting Single Session Consultation for Cancer (SSC-C) to Alleviate Distress Among Breast Cancer Patients

NCT ID: NCT07218250Sponsor: Memorial Sloan Kettering Cancer CenterLast updated: 2026-06-08

Summary

The purpose of this study is to see if a Single Counseling Session for Cancer can help reduce psychosocial distress and improve quality of life in people with breast cancer who are waiting to receive ongoing counseling services (outpatient psychotherapy services). The Single Counseling Session for Cancer-which I will refer to as the "study counseling" during this call-is a one-session, 60-minute counseling program designed to reduce anxiety and depression symptoms in people with cancer who are waiting to receive outpatient psychotherapy services. The researchers will look at whether the study counseling is effective in participants and practical (feasible) for them to complete.

Arms & interventions

  • BehavioralSingle Counseling Session

    The one-time counseling session will be a problem-solving focused program that will try to strengthen the belief in the ability to manage the challenges of the cancer diagnosis and treatment

  • OtherAmerican Cancer Society booklet

    called "After Diagnosis: A Guide for Patients and Families" for review. Again, this booklet includes information about cancer, living with cancer, making treatment decisions, talking to others about cancer, cancer treatment, and questions for the cancer care team. It will be given in person or by email.

Outcome measures

Primary

  • Acceptability (SSC-C participants)

    Participants will complete a satisfaction survey after completing the SSC-C intervention. A 5-item, investigator- initiated, face-valid satisfaction survey will assess the degree with which participant found SSC-C helpful in developing an action plan to address their concerns, their perceived utility of the action plan, the degree with which they believe they will use the action plan, their motivation to do so, and the extent to which they will recommend SSC-C to other patients.

    Time frame: up to 3 months

  • Acceptability (PPSB participants)

    Participants will complete a satisfaction survey after receiving PPSB intervention materials. A 6-item, investigator- initiated, face-valid satisfaction survey will assess the degree with which participants found PPSB intervention helpful in developing an action plan to address their concerns, their perceived utility of the booklet, the degree with which they believe they will use the booklet, their motivation to do so, and the extent to which they will recommend the booklet materials to other patients.

    Time frame: up to 3 months

Secondary

  • Psychosocial distress

    Time frame: up to 3 months

Eligibility criteria

Sex: FemaleAge: 18 Years and olderHealthy volunteers: No
Inclusion Criteria: * Patient must have pathologically confirmed breast cancer (per EMR). * Patient with localized or advanced cancer (per EMR). * Patient is on a waitlist of at least 2 weeks or more for MSK Counseling Center intake and will not complete a New Visit with a clinical psychologist prior to intervention (these patients will be replaced) (per EMR, patient's care team, or self-report) * Has not had and is not scheduled to have an appointment with an MSK psychiatrist or MSK Counseling Center advanced practice provider (per EMR, patient's care team, or self-report) * Female (per EMR) * Age ≥ 18 (per EMR) * English fluency - Per self-report: How well do you speak English? * Agrees to be audio-recorded (per self-report) NOTE: Participants who report Very well are considered fluent. * Lives in New York, New Jersey, Connecticut, or Florida (per self-report). * Has no significant psychiatric disturbance sufficient to preclude completion of the assessment measures, interview, or informed consent (i.e., acute psychiatric symptoms which require urgent or extended individual treatment) (per EMR, patient's care team, or study team). * Has no presence of cognitive impairment disorder (i.e., delirium, dementia, or traumatic brain injury) sufficient to preclude meaningful informed consent and/or data collection (per EMR, patient's care team, study team, or per self-report of BOMC cognitive test). * Has no current active or passive suicidal ideation ((per EMR, patient's care team, study team, per item 9 of the PHQ-9, or the CSSRS).

Study locations (7)

Memorial Sloan Kettering Basking Ridge (Consent Only)

Basking Ridge, New Jersey, 07920

Recruiting
Devika Jutagir, PhD · Contact

Memorial Sloan Kettering Monmouth (Consent Only)

Middletown, New Jersey, 07748

Recruiting
Devika Jutagir, PhD · Contact

Memorial Sloan Kettering Bergen (Consent Only)

Montvale, New Jersey, 07645

Recruiting
Devika Jutagir, PhD · Contact

Memorial Sloan Kettering Suffolk- Commack (Consent Only)

Commack, New York, 11725

Recruiting
Devika Jutagir, PhD · Contact

Memorial Sloan Kettering Westchester (Consent Only)

Harrison, New York, 10604

Recruiting
Devika Jutagir, PhD · Contact

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

New York, New York, 10065

Recruiting
Devika Jutagir, PhD · Contact

Memorial Sloan Kettering Nassau (Consent Only)

Uniondale, New York, 11553

Recruiting
Devika Jutagir, PhD · Contact